Technical Analysis
Health
Growth
Action
Targets into 2028
- The stock price for Oracle
ORCL touched the top of my selected historical simple moving average zone. This is often a strong area of support / resistance / algorithmic share accumulation. While the share price may fall into to $150's or slightly lower in the near-term, the long-term growth looks very promising.
Health
- Debt-to-equity: 4.4x (of some concern)
- Quick ratio / short-term debt: 0.9 (not great)
- Altman's Z-score / long-term debt / bankruptcy risk: 2.5 (minor risk)
Growth
- 105.5% earnings-per-share growth projected between 2025 ($7.39) and 2028 ($15.19)
- 162.5% revenue growth projected between 2025 ($66.9 billion) and 2028 ($175.6 billion)
Action
- While there may be near-term weakness to the $150's and lower,
ORCL is in a personal buy zone /starter position at $172.42.
Targets into 2028
- $217.00 (+25.9%)
- $270.00 (+56.6%)
Trade active
Target #1 reached resulting in a +25.9% gain.If you enjoy this idea, please follow for more: tradingview.com/u/WorthlessViews/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
If you enjoy this idea, please follow for more: tradingview.com/u/WorthlessViews/
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
